The following authors and panelists reported that they have a financial interest, relationship, or affiliation that could be perceived as a potential conflict of interest in the context of their contributions to this supplement:

• Gail H. Cassell, PhD, DSc (hon), reported that she receives a salary, grant/research support, and stock options from Eli Lilly and Co. (her employer).
  
• Paul A. LaViolette, MBA, reported that he receives a salary from and holds ownership interest in Boston Scientific Corp. (his employer).
  
• James G. Sheehan reported that he receives a salary from the US Deparment of Justice (his employer).
  
• Thomas P. Stossel, MD, reported that he has ownership interests in ZymeQuest, Inc., and in Critical Biologics Corp.; has intellectual property rights in Critical Biologics Corp.; has received consulting/advisory fees from Merck, Inc.; has received honoraria from Pfizer, Inc.; and has received royalties from Lippincott Williams & Wilkins.
  

The following authors and panelists reported that they have no financial interests, relationships, or affiliations that could be perceived as a potential conflict of interest in the context of their contributions to this supplement:

• Claudia R. Adkison, JD, PhD
  
• Guy M. Chisolm III, PhD
  
• Delos M. Cosgrove, MD
  
• Susan H. Ehringhaus, JD
  
• Jeffrey P. Kahn, PhD, MPH
  
• Darrell G. Kirch, MD
  
• Edward D. Miller, MD
  
• Philip A. Pizzo, MD
  
• Norka Ruiz Bravo, PhD
  
• Bernard A. Schwetz, DVM, PhD
  
• Edward Soule, CPA, PhD
  
• Dick Thornburgh
  
• Nina Totenberg
  
• P. Roy Vagelos, MD
  

   

CCJM Home | Current Issue | Past Issues | Supplements

Instructions for Authors | Subscriptions | Advertising
Rates | CME Department

Cleveland Clinic Foundation | Division of Education | Notice of Privacy Practices
Disclaimer | Privacy | © 2007  October 1, 2007